Patrizia Porazzi

11PUBLICATIONS
133CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 15, 2026
Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy.

|Feb 06, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.

Zhiwei Ang, Annette Castro, Luca Paruzzo

|Feb 04, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

Ivan J Cohen, Audrey C Bochi-Layec, Jean Lemoine

|Jan 06, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.

Alberto Carturan, Mathew G Angelos, Puneeth Guruprasad

|Oct 21, 2025
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy.

Ángel Ramírez-Fernández, Alexander J Dimitri, Fang Chen

|Jul 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

Ruchi P Patel, Guido Ghilardi, Yunlin Zhang

Pageof 2

Frequent Collaborators

8 joint publications

Marco Ruella

6 joint publications

Luca Paruzzo

5 joint publications

Stephen J Schuster

5 joint publications

Raymone Pajarillo